Introduction {#Sec1}
============

Headache is the most common type of pain experienced by man. Even though headache receives little attention probably due to the often mild symptoms, the fact is that most people rarely consult their physician for headache \[[@CR1], [@CR2]\]. However, the high prevalence and the considerable socioeconomic impact render that suffering from headache should not be ignored \[[@CR2]--[@CR4]\]. The most common types of headache, such as migraine and tension-type headache, cause 270 days and 820 days of work absence per year per 1,000 people \[[@CR2]\]. "Lifting the burden", a global campaign to reduce the burden of headache worldwide concluded that headache is among the ten most disabling conditions in the World Health Organizations ranking \[[@CR4]\].

The aim of this study is to provide epidemiological data on migraine and headache among 20--80-year- old people from the Norwegian general population.

Subjects and methods {#Sec2}
====================

Sampling and representativeness {#Sec3}
-------------------------------

A random sample of 40,000 persons aged 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75 and 80 years was drawn by the National Population Register. The sample was stratified by age and gender, i.e., each age group included 2,000 persons of each gender, aged 30--60 years, while the remaining age groups included 1,000 persons of each gender. The participants were residing in Akershus, Hedmark or Oppland Counties, excluding the municipalities Asker and Bærum and municipalities north of Trysil, Åmot, Ringsaker, Vestre Slidre, Østre Slidre, Gausdal and Øyer. The sample size was reduced to 38,873 owing to decease (*n* = 75), dementia (*n* = 23), multihandicapped (*n* = 4), insufficient Norwegian skills (*n* = 3), and an error in the address list (*n* = 1,024).

The three counties have both rural and urban areas and Akershus County is situated in close proximity to Oslo. Data from Statistics Norway show that the sampling area was representative for the total Norwegian population regarding age, gender and marital status*.* Regarding employment; trade, hotel/restaurant and transport were overrepresented, while industry, oil and gas and financial services were underrepresented in the sampling area compared to the total Norwegian population \[[@CR5]\].

Questionnaire {#Sec4}
-------------

All persons received a mailed questionnaire with a standard letter containing information about the project. Apart from ensuring confidentiality and emphazising the importance of participation, it was stated that the object was to study sleepiness during daytime. The questions "Have you ever had migraine? Yes or no", and "How many days during the last year have you had headache? 0 days, 1--11 days, 12--30 days, 31--84 days, 85--179 days or ≥180 days" were used to screen for migraine and headache frequency. If the questionnaire evoked no response, a second mail was issued. The replies could be either on paper or electronically. The data were collected between February and August 2006. We defined infrequent headache to be less than 12 days per year, frequent headache to be between 12 and 179 days per year, while chronic headache was 180 days or more per year \[[@CR1]\].

Statistical analyses {#Sec5}
--------------------

All questionnaires were scanned using TeleForm v9. The statistical analyses were performed using SPSS Base System for Windows 15.0. The 95% CI were calculated with the Vassar Collage statistics web-page \[[@CR6]\]. χ^2^ test with 5% level of significance was used. Non-linear regression analysis was applied to explore the trends in the prevalence of different headache frequency, age and gender groups. Headache frequency can be considered as a count or ordinal variable. Firstly, the Poisson regression model was explored, when modeling the differences in headache frequency. Although the assumptions for the Poisson regression model were reasonable, the fit was rather poor in this model. Secondly, the ordinal logistic regression model was considered. However, the assumption of parallel lines was not met, and this model was rejected. Thus, the multinomial logistic regression model was estimated to quantify the differences in headache frequency in relation to age, gender, age and co-occurrence of migraine.

Ethical issues {#Sec6}
--------------

The Regional Committees for Medical Research Ethics and the Norwegian Social Science Data Services approved the project.

Results {#Sec7}
=======

Questionnaire response rate {#Sec8}
---------------------------

The overall response rate was 54.5%, and it was significantly higher among women than men (*P* \< 0.001). Table [1](#Tab1){ref-type="table"} shows the response rate by age and gender. The response rate increased steadily from age 20 to age 65 years, and then it slowly declined in the elder age groups. Among responders, the first, second, and electronic questionnaire were replied by 64.7, 27.0 and 8.3%, respectively. There were no significant differences between headache and migraine response to first, second and electronic version analyzed separately by age and gender. The electronic version was replied significantly by more men than women (men 11.6% vs. women 5.3%; *P* \< 0.001), and the response rate increased slightly from age 20 to age 25, then it declined gradually to 1.0 and 0.0% among 80 old men and women (*P* \< 0.001 in both gender). Information about headache was missing in 5.9% of men and 4.8% of women, while information about migraine was missing in 6.6% of men and 5.2% of women. Complete information on both headache and migraine was received by 88.0% of men and 89.4% of women.Table 1Questionnaire response rates by age and genderAgeMen % (95% CI)Women % (95% CI)2030.3 (27.4--33.3)43.6 (40.4--46.9)2530.7 (27.8--33.8)46.3 (43.1--49.6)3038.8 (36.5--41.0)49.0 (46.8--51.3)3542.5 (40.2--44.7)52.7 (50.4--54.9)4050.7 (48.4--52.9)57.8 (55.6--60.0)4551.7 (49.5--54.0)57.0 (54.8--59.2)5054.1 (51.8--56.3)63.1 (61.0--65.3)5559.0 (56.8--61.2)64.3 (62.2--66.4)6060.1 (57.9--62.3)64.3 (62.2--66.4)6570.6 (67.7--73.4)67.8 (64.8--70.7)7070.3 (67.3--73.1)64.1 (61.0--67.1)7564.5 (61.4--67.4)55.7 (52.5--58.8)8055.0 (51.8--58.2)44.4 (41.3--47.6)Overall response rate51.9 (51.2--52.6)57.0 (56.3--57.7)*CI* confidence intervals

Migraine {#Sec9}
--------

Table [2](#Tab2){ref-type="table"} shows the prevalence of migraine by age and gender. Women had significantly more frequent migraine than men \[34.1% (95% CI 33.2--35.0%) vs. 18.1% (95% CI 25.9--27.1%), *P* \< 0.001\]. The prevalence in men was unchanged from age 20 to age 40 years, and then it decreased slightly with age, while the prevalence in women increased from age 20 to age 40 years, and then decreased slightly with increasing age.Table 2Lifetime prevalence of migraine related to age and genderAgeMen % (95% CI)Women % (95% CI)2021.8 (17.2--27.3)31.4 (26.9--36.4)2522.6 (17.8--28.3)34.5 (30.0--39.4)3020.5 (17.6--23.8)36.8 (33.6--40--1)3521.8 (19.0--25.0)37.8 (34.7--40.9)4022.0 (19.3--24.8)38.0 (35.1--41.0)4520.6 (18.1--23.4)37.4 (34.5--40.4)5018.3 (15.9--20.9)33.7 (31.0--36.5)5518.4 (16.2--20.9)35.4 (32.7--38.3)6018.0 (15.8--20.4)34.8 (32.2--37.6)6514.1 (11.6--17.1)31.0 (27.4--34.8)7011.6 (9.3--14.4)25.9 (22.5--29.7)7513.5 (10.9--16.5)24.3 (20.7--28.3)8010.9 (8.4--14.0)27.2 (22.9--31.9)Overall prevalence18.1 (17.3--18.9)34.1 (33.2--35.0)*CI* confidence intervals

Headache {#Sec10}
--------

The 1 year prevalence of headache was 77.2%, i.e., 69.6% (95% CI 68.7--70.6%) in men and 84.0% (95% CI 83.3--84.7%) in women. Table [3](#Tab3){ref-type="table"} shows headache frequency in relation to migraine, age and gender. The frequency of headache decreased with age, but some of the elders aged 70 years or above experienced more frequent headache. The risk and frequency of headache was significantly higher in those with than without co-occurrence of migraine (*P* \< 0.001 for both the gender). Table [4](#Tab4){ref-type="table"} presents the results of a multinomial logistic regression model showing odds ratios in relation to headache frequency, age and gender, with headache free and age 40 years old as reference categories. Intercept was included in the model, but is not show in the table. The Pearson χ^2^ values were insignificant for both the models indicating that the estimated multinomial regression models fit data reasonably well. Table [5](#Tab5){ref-type="table"} shows age trends in different subgroups assessed using the non-linear regression model for each gender separately. This fit was rather good, with moderate or high values of *R*^2^ and normally distributed residuals. In some subgroups the linear regression gave best fit, however,graphical analysis of the data showed that most subgroups displayed a curvilinear relationship (second or third order) between headache frequency and age (Fig. [1](#Fig1){ref-type="fig"}).Table 3Headache frequency in relation to migraine, age and gender in people from the Norwegian general populationAge (years)*N*No headacheInfrequent headacheFrequent headacheChronic headache0 days (%)1--11 days (%)12--30 days (%)31--84 days (%)85--179 days (%)≥180 days (%)*No migraine* *Men*  2020219.355.021.34.00.50.0  2519715.756.917.88.61.00.0  3051214.853.119.98.02.71.4  3556315.556.114.98.23.02.3  4067416.355.016.28.04.00.4  4570020.455.612.17.73.11.0  5075427.950.012.95.42.41.5  5583035.345.311.94.11.61.8  6085841.742.89.03.61.71.2  6551750.139.76.62.10.21.4  7052156.833.04.44.01.00.8  7547363.825.64.74.21.10.6  8039574.715.23.34.11.31.5  Total7,19634.745.211.45.52.01.2 *Women*  202555.147.125.514.17.80.4  252627.345.428.211.55.71.9  305288.947.223.911.65.92.7  355756.845.224.213.96.83.1  406466.846.426.012.46.22.2  4564410.746.724.212.43.42.5  5073914.651.320.67.83.81.9  5571122.648.815.58.63.11.4  6072323.951.012.66.93.02.5  6539934.639.311.89.03.51.8  7040045.035.010.86.31.31.8  7534851.433.97.85.70.60.6  8023661.421.68.13.42.53.0  Total6,46620.345.018.89.74.12.1*Co-occurrence of migraine Men*  20601.738.333.318.35.03.3  25603.336.731.718.38.31.7  301383.628.326.829.06.55.8  351623.734.635.817.34.93.7  401973.033.528.918.311.25.1  451912.135.624.123.08.96.3  501755.732.031.417.110.33.4  5519313.037.824.414.07.33.6  6019613.847.416.39.77.75.1  658719.550.613.811.52.32.3  707027.142.915.710.04.30.0  757433.825.714.917.64.14.1  804930.642.910.214.30.02.0  Total1,6529.836.924.817.17.24.1 *Women*  201170.924.821.430.814.57.7  251420.024.630.324.615.54.9  303231.922.931.626.010.57.1  353590.622.325.130.115.36.7  404111.019.527.329.713.19.5  453922.022.231.925.510.77.7  503833.427.925.822.513.17.3  554055.433.128.121.07.94.4  604088.339.021.616.97.46.9  6518115.537.023.213.37.23.9  7014626.732.218.517.82.72.1  7511231.334.811.612.54.55.4  809239.121.713.016.35.44.3  Total3,4716.627.625.723.210.56.5The sum of each row is 100%Table 4Headache analyzed with a multinomial logistic regression modelAge and migraineMenWomenOdds ratios95% CI*P* valuesOdds ratios95% CI*P* values*1--11 days* 200.8790.583--1.3240.5371.3840.741--2.5870.308 251.0690.693--1.6490.7641.0360.589--1.8200.903 301.0310.749--1.4200.8500.7680.505--1.1670.216 351.0620.782--1.4440.7001.0510.675--1.6350.827 401----1---- 450.8260.626--1.0900.1760.6340.430--0.9340.021 500.5270.405--0.684\<0.0010.5080.354--0.729\<0.001 550.3730.290--0.480\<0.0010.3250.230--0.459\<0.001 600.3120.244--0.400\<0.0010.3130.223--0.441\<0.001 650.2390.183--0.313\<0.0010.1690.117--0.242\<0.001 700.1730.132--0.227\<0.0010.1070.075--0.154\<0.001 750.1130.085--0.151\<0.0010.0920.064--0.133\<0.001 800.0700.051--0.096\<0.0010.0480.032--0.073\<0.001 Migraine2.8772.385--3.470\<0.0011.9811.679--2.337\<0.001 No migraine1----1----*12--30 days* 201.0650.664--1.7080.7931.1980.629--2.2810.583 251.1170.675--1.8470.6671.0900.612--1.9420.769 301.2410.858--1.7930.2520.7320.476--1.1270.157 351.0680.746--1.5300.7190.9650.612--1.5210.879 401----1---- 450.6240.444--0.8770.0070.6190.415--0.9230.019 500.4940.358--0.680\<0.0010.3570.244--0.521\<0.001 550.3170.231--0.434\<0.0010.1980.137--0.286\<0.001 600.1900.137--0.263\<0.0010.1380.095--0.199\<0.001 650.1160.078--0.173\<0.0010.0890.059--0.134\<0.001 700.0790.051--0.121\<0.0010.0540.036--0.082\<0.001 750.0700.045--0.109\<0.0010.0320.020--0.051\<0.001 800.0420.024--0.071\<0.0010.0280.017--0.045\<0.001 Migraine7.6666.230--9.433\<0.0014.5233.797--5.387\<0.001 No migraine1----1----*31--84 days* 200.5870.314--1.0960.0941.3890.717--2.6910.330 251.0600.589--1.9090.8460.8540.464--1.5690.610 301.3480.884--2.0580.1660.6430.409--1.0120.056 351.0270.674--1.5640.9011.1030.690--1.7620.682 401----1---- 450.8610.586--1.2660.4470.5460.359--0.8320.005 500.4280.289--0.635\<0.0010.2840.190--0.426\<0.001 550.2430.163--0.362\<0.0010.1740.118--0.257\<0.001 600.1580.105--0.239\<0.0010.1220.082--0.182\<0.001 650.0970.057--0.166\<0.0010.0820.053--0.128\<0.001 700.1210.074--0.197\<0.0010.0540.035--0.085\<0.001 750.1290.081--0.206\<0.0010.0370.023--0.061\<0.001 800.0990.059--0.166\<0.0010.0270.016--0.048\<0.001 Migraine11.1688.896--14.021\<0.0017.9786.633--9.596\<0.001 No migraine1----1----*85--179 days* 200.2260.076--0.6720.0071.5420.755--3.1510.235 250.4860.199--1.1850.1121.0460.540--2.0280.893 300.7060.396--1.2600.2390.6200.372--1.0310.066 350.6370.363--1.1180.1161.1860.711--1.9790.514 401----1---- 450.6300.384--1.0330.0670.4170.256--0.679\<0.001 500.4000.244--0.655\<0.0010.3310.210--0.522\<0.001 550.1970.117--0.333\<0.0010.1380.086--0.220\<0.001 600.1740.104--0.289\<0.0010.1140.072--0.183\<0.001 650.0260.008--0.084\<0.0010.0790.046--0.137\<0.001 700.0640.029--0.140\<0.0010.0210.010--0.044\<0.001 750.0580.026--0.126\<0.0010.0170.007--0.038\<0.001 800.0400.015--0.103\<0.0010.0280.014--0.057\<0.001 Migraine12.6649.413--17.037\<0.0018.5526.856--10.667\<0.001 No migraine1----1----*≥180 days* 200.4260.092--1.9840.2770.7510.303--1.8620.536 250.2620.033--2.0840.2050.6050.264--1.3880.236 301.7330.778--3.8610.1780.6250.349--1.1170.113 351.8260.852--3.9120.1220.9410.523--1.6950.839 401----1---- 451.1560.545--2.4520.7050.5310.309--0.9130.022 500.7110.332--1.5230.3810.3160.186--0.539\<0.001 550.6060.294--1.2500.1750.1260.071--0.221\<0.001 600.4370.210--0.9120.0270.1770.106--0.296\<0.001 650.2890.119--0.6990.0060.0730.037--0.143\<0.001 700.1200.038--0.378\<0.0010.0410.019--0.086\<0.001 750.1630.060--0.442\<0.0010.0340.015--0.076\<0.001 800.2090.080--0.5410.0010.0490.024--0.103\<0.001 Migraine12.1698.498--17.425\<0.00110.3587.967--13.467\<0.001 No migraine1----1----Table 5The age trends in different subgroups were assessed using the non-linear regression model for each gender separatelyDependent variableCoefficients of regression model*P* values*R*^*2*^*b*~0~*b*~1~*b*~2~*b*~3~*No migraine* *Men*  0 days30.43−1.120.02--\<0.0010.988  1--11 days39.341.07−0.02--\<0.0010.985  12--30 days27.03−0.30----\<0.0010.957  31--84 days−19.051.94−0.040.0003\<0.0010.869  85--179 days−15.381.20−0.020.0001\<0.0010.855  ≥180 days−5.540.40−0.010.000040.1970.390 *Women*  0 days23.04−1.210.02--\<0.0010.991  1--11 days22.881.32−0.016--\<0.0010.835  12--30 days29.49−0.03−0.003--\<0.0010.924  31--84 days17.41−0.16----\<0.0010.822  85--179 days9.20−0.10----\<0.0010.821  ≥180 days−9.890.83−0.020.00010.0560.550*Co-occurrence of migraine* *Men*  0 days11.55−0.620.01--\<0.0010.949  1--11 days89.72−4.180.09−0.0010.3060.317  12--30 days43.30−0.39----\<0.0010.804  31--84 days−19.613.15−0.070.00050.0360.596  85--179 days−2.990.54−0.006--0.0050.660  ≥180 days−0.0040.20−0.002--0.1990.276 *Women*  0 days21.80−1.330.02--\<0.0010.980  1--11 days94.78−5.620.13−0.001\<0.0010.832  12--30 days11.940.87−0.01--\<0.0010.809  31--84 days36.41−0.29----\<0.0010.778  85--179 days19.68−0.20----\<0.0010.796  ≥180 days9.00−0.06----0.0370.338Fig. 1Headache frequency versus age in men (*first row*) and women (*second row*)

Headache free {#Sec11}
-------------

The prevalence of being headache free increased from 19.1% (95% CI 14.2--25.6%) to 74.7% (95% CI 70.0--78.8%) in 20 and 80-year-old men without co-occurrence of migraine, and from 5.1% (95% CI 2.9--8.8%) to 61.4% (95% CI 54.9--67.6%) in 20 and 80-year-old women without co-occurrence of migraine. The prevalence of being headache free increased from 1.7% (95% CI 0.1--10.1%) to 30.6% (95% CI 18.7--45.6%) in 20 and 80-year-old men with co-occurrence of migraine, and from 8.5% (95% CI 0.4--53.6%) to 39.1% (95% CI 29.3--49.9%) in 20 and 80-year-old women with co-occurrence of migraine.

Discussion {#Sec12}
==========

Methodological considerations {#Sec13}
-----------------------------

The study included 21,177 persons at age 20--80 years, providing sufficient data for age and gender-specific prevalence of headache and migraine. Participation was restricted to those responding to the migraine and headache questions. The response rate was fair and there were few missing values. We were not able to investigate whether responder and non-responders had a similar migraine and headache pattern, since we were not allowed to contact non-responders. However, similar replies to the first and second issued questionnaire as well as electronic responses suggest that responders and non-responders are not different. A previous Danish epidemiological survey found no significant difference in the frequency of migraine among responders and non-responders \[[@CR7]\]. The single question about lifetime occurrence of migraine has been evaluated against a clinical interview by two physicians in another Norwegian survey conducted in eastern Akershus County. The observed agreement rate was 0.81 and Kappa was 0.62, a good strength of agreement (previous unpublished data). This is in line with validation of two Danish epidemiological surveys where the observed agreement rate was 0.92 and 0.94, and Kappa was 0.77 and 0.81, respectively \[[@CR7], [@CR8]\]. A single questionnaire question about tension-type headache has previously been evaluated against a clinical interview by a physician in a Danish population-based survey \[[@CR8]\]. The observed agreement rate was 0.91 and the chance corrected agreement rate Kappa was 0.74, i.e., a good strength of agreement. The frequency of tension-type headache among 475 persons, aged 25--64-year- old, from the Danish general population, i.e., none, infrequent, frequent and chronic tension-type headache was also evaluated against a clinical interview by a physician on the same day in those with self-reported tension-type headache. The observed agreement rate was 0.87 and the chance corrected agreement rate Kappa was 0.77, again a good strength of agreement \[[@CR9]\]. Our question regarding headache is likely to be more or at least equally precise as a single question about tension-type headache, since everybody knows what headache is, while some may not know what tension-type headache is. Thus, our simple questionnaire on migraine and headache is considered to be valid, even though our epidemiological survey included persons aged 20--80 years. It would be quite surprising, if 20 years old and 70--80 years old were significantly different from 25 to 65 years old regarding our simple questions about migraine and headache. In contrast, questionnaires based on a series of questions are not valid \[[@CR8]\]. Due to the high number of participants in our survey, it was not feasible to apply the gold standard, i.e., a clinical interview by a physician/neurologist with expertise in headache diagnostics. The prevalence was based on headache within the last year. This was chosen in order to reduce recall bias. As headache is usually not a disabling or life threatening disorder, recall bias is likely to occur if one asks about headache years ago. Actually, the use of the 1-year prevalence is likely to secure more precise data on headache. Thus, the methodological precautions should secure that the data are both representative and generalizable.

Migraine {#Sec14}
--------

One of our main findings was the 26.5% lifetime prevalence of migraine with a male--female sex ratio of approximately 1:2. Our lifetime prevalence is quite similar to that found in other epidemiological surveys of Caucasians conducted in Germany, the Netherlands and Sweden, while it is higher than that found in Canada, Croatia, Denmark and Italy \[[@CR7], [@CR10]--[@CR15]\]. The different methodologies of these epidemiological surveys are likely to explain a part of the variation in prevalence. The prevalence of migraine is much lower in Africans, Asians and South Americans \[[@CR4]\]. Although we do not have data on the frequency of migraine attacks, the high prevalence indicate that many people experience migraine at least a few times in their life, supporting the high socioeconomic impact of migraine \[[@CR2]--[@CR4]\]. The statistically significantly decreased prevalence of migraine in elder men can be a true phenomenon or it might be caused by recall bias. Women also had a tendency of decreased prevalence by age, but this was not statistically significant. Since, the epidemiological survey was population-based, the prevalence finding cannot be explained by physician consultation rate differences.

Headache {#Sec15}
--------

Another main finding was the 77.2% 1-year prevalence of headache with a male--female sex ratio of approximately 1:1.2. This corresponds well with the prevalence found in neighboring countries Denmark, Finland and Sweden \[[@CR16]--[@CR18]\]. However, another Norwegian epidemiological survey found a much lower prevalence of headache \[[@CR19]\]. The latter survey was based on the question have you suffered from headache during the last 12 months? \[[@CR20]\]. This phrasing is likely to cause underestimation of the "real" prevalence of headache, as people with a mild headache might not reply yes to question about suffering from headache. An interesting finding was the slightly increased risk of frequent and chronic tension-type in some of the elders. Figure [1](#Fig1){ref-type="fig"} gives a graphical presentation of this aspect. This increase is likely to be secondary to other causes like stroke, tumors, etc., which become more common with age. An increase in headache frequency is a warning sign and should be dealt seriously with proper investigations. The data clearly demonstrated that co-occurrence of migraine increased the risk of headache. This has also been found in other epidemiological surveys \[[@CR9], [@CR21], [@CR22]\]. Whether frequent headaches can cause attacks that mimics migraine or whether abortive attacks of migraine can be experienced as headache is uncertain. This is currently being debated among headache researchers, but it is not the scope of our paper. However, even thought the etiology is unsolved, the features of migraine and non-migraine headache are distinct and non-overlapping, as defined by the explicit diagnostic criteria of the International Classification of Headache Disorders \[[@CR1]\]. The prevalence of being headache free increased significantly with age, and this is more so in men than in women, and in those without co-occurrence of migraine than those with the co-occurrence of migraine. So, even thought a person has frequent episodes of headache and migraine there is hope at the end of the tunnel.
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